Human DNA Vaccines Market: Global Analysis and Opportunity and Forecast by 2024: MedImmune, Sanofi, Astellas Pharma, CureVac
Human DNA vaccines are third generation vaccines meant to produce immune response against disease. The increasing risk of infectious diseases and rising number of antibiotics resistant demands cost effective vaccination solutions.
View full press release